You are here: Home » International » News » Markets
Omicron variant brings Covid-19 vaccine inequity 'home to roost'
Volvo Cars sees chip shortage extending into 2022, Q3 profit dips
Business Standard

Moderna's concerns about Omicron outlook spark market slump

The companies that bet on messenger RNA vaccines -- BioNTech SE and its partner Pfizer Inc. as well as Moderna -- have an advantage in that they can be swift to develop a new injection

Topics
Coronavirus | Coronavirus Vaccine | Coronavirus Tests

Michelle Fay Cortez | Bloomberg 



moderna

Moderna Inc.’s top executives reiterated that the omicron variant’s many mutations suggest new vaccines will be needed, triggering a slump in financial .

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Tue, November 30 2021. 14:44 IST

RECOMMENDED FOR YOU

.